Michael Kelliher
Directeur/Bestuurslid bij CAPRICOR THERAPEUTICS, INC.
Vermogen: 1 M $ op 30-04-2024
Profiel
Michael Kelliher is currently an Independent Director at Capricor Therapeutics, Inc. since 2023 and an Executive VP-Corporate Development & Strategy at Ardelyx, Inc. since 2024.
Previously, he worked as a Group Vice President-Merger & Acquisition at Horizon Therapeutics Plc.
He completed his undergraduate degree at University College Cork.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
ARDELYX, INC.
0.07% | 25-03-2024 | 160 000 ( 0.07% ) | 1 M $ | 30-04-2024 |
| 18-03-2024 | 0 ( -.--% ) | - $ | 30-04-2024 |
Actieve functies van Michael Kelliher
| Bedrijven | Functie | Begin |
|---|---|---|
| CAPRICOR THERAPEUTICS, INC. | Directeur/Bestuurslid | 01-09-2023 |
| ARDELYX, INC. | Corporate Officer/Principal | 25-03-2024 |
Eerdere bekende functies van Michael Kelliher
| Bedrijven | Functie | Einde |
|---|---|---|
| HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Corporate Officer/Principal | - |
Opleiding van Michael Kelliher
| University College Cork | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| CAPRICOR THERAPEUTICS, INC. | Health Technology |
| ARDELYX, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Horizon Therapeutics Plc
 Horizon Therapeutics Plc Pharmaceuticals: MajorHealth Technology Horizon Therapeutics Plc is a biopharmaceutical company, which engages in the research, development, and marketing of pharmaceutical products. It operates through the Orphan and Inflammation segments. The Orphan segment consists of medicines KRYSTEXXA, RAVICTI, PROCYSBI, ACTIMMUNE, BUPHENYL, QUINSAIR, and RAYOS. The Inflammation segment comprises medicines PENNSAID 2%, DUEXIS, and VIMOVO. The company was founded in 2008 and is headquartered in Dublin, Ireland. | Health Technology |